Review
Copyright ©The Author(s) 2021.
World J Clin Oncol. Aug 24, 2021; 12(8): 581-608
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.581
Table 5 Dose constraints in organs at risk
Organs at risk
Dose constraints
Lungs-GTVV20 < 37%, Mean dose < 20 Gy
Contralateral lung-PTVV20 < 20%, V5 < 17%, Mean dose < 8 Gy
Ipsilateral lungV40 < 67%, Mean dose < 36 Gy
Heart defined as pericardial sacRight mesothelioma V40 < 25%; Left mesothelioma V40 < 35%
Brachial plexusMaximum dose < 65 Gy
EsophagusV55 Gy < 30%; Mean dose < 34 Gy
Stomach minus including PTVMean dose < 30 Gy
Bowel Maximum dose < maximum PTV < 55 Gy; D5 cc < 50 Gy
Spinal cordMaximum dose < 50 Gy
Liver minus GTVV30 < 45%; Mean dose < 30 Gy
Kidneys evaluated separatelyV18 < 33% (or V18 < 50%, if cannot be achieved at ≤ 33%)
Ipsilateral kidney; Contralateral kidneyV25 < 40%; V10 < 10%